Risperdal and Acthar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 2 people who take Risperdal and Acthar. Common interactions include appetite disorder among females.

The phase IV clinical study analyzes what interactions people who take Risperdal and Acthar have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2023

2 people who take Risperdal and Acthar together, and have interactions are studied.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is used in bipolar disorder. Currently, eHealthMe is studying from 124,653 Risperdal users.

What is Acthar?

Acthar has active ingredients of corticotropin. Currently, eHealthMe is studying from 4,893 Acthar users.

Number of Risperdal and Acthar reports submitted per year:

Common Risperdal and Acthar drug interactions by gender *:

female:

Appetite disorder
Asthenia
Tension
Drug ineffective
Fatigue
Muscular weakness
Myopathy
Polymyositis
Weight decreased
Anxiety

male:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal and Acthar?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

Related studies

Drug side effects by duration, gender and age:

Risperdal side effects (124,653 reports)
Acthar side effects (4,893 reports)

Common Risperdal drug interactions:

Risperdal and Invega: 20,942 reports
Risperdal and Seroquel: 9,028 reports
Risperdal and Zyprexa: 6,572 reports
Risperdal and Abilify: 5,828 reports
Risperdal and Depakote: 4,358 reports
Risperdal and Risperidone: 3,474 reports
Risperdal and Haldol: 3,113 reports
Risperdal and Zoloft: 2,942 reports
Risperdal and Lorazepam: 2,817 reports
Risperdal and Loraz: 2,655 reports

Browse interactions between Risperdal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Acthar drug interactions:

Acthar and Prednisone: 528 reports
Acthar and Vitamin d: 272 reports
Acthar and Gabapentin: 218 reports
Acthar and Baclofen: 208 reports
Acthar and Lisinopril: 195 reports
Acthar and Ampyra: 191 reports
Acthar and Methotrexate: 182 reports
Acthar and Omeprazole: 177 reports
Acthar and Aspirin: 175 reports
Acthar and Furosemide: 150 reports

Browse interactions between Acthar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on risperidone and corticotropin (the active ingredients of Risperdal and Acthar, respectively), and Risperdal and Acthar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Risperdal and Acthar.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Effexor and Agitation Neonatal - a second ago
Sulfamethoxazole and Nicotrol drug interaction - 8 seconds ago
Azopt and Pancytopenia - 19 seconds ago
Levaquin and Losartan Potassium drug interaction - 27 seconds ago
Repatha and Acute Coronary Syndrome - 34 seconds ago
Rosehip and Losartan Potassium drug interaction - 38 seconds ago
Ambrisentan and Left Ventricular Failure - 39 seconds ago
Mucinex Dm and Vitamin E drug interaction - 41 seconds ago
Centrum and Synovial Cyst - 49 seconds ago
Olanzapine and Pathological Gambling - 52 seconds ago